rxstat › Shortages › Carbamazepine
Carbamazepine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Carbamazepine products are in shortage in Canada (2 of 20 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 26, 2026.
In shortage since
Oct 22, 2014
Est. full return
Jun 26, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTARO-CARBAMAZEPINE
100MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02367394 · since Jan 23, 2026, est. end Jun 26, 2026 · Disruption of the manufacture of the drug.
Active shortageMAZEPINE
BIOMED PHARMA
DIN 00504742 · since Oct 22, 2014, no end estimate · Other (Please describe in comments)
ResolvedTEVA-CARBAMAZEPINE
200MG · TABLET · TEVA CANADA LIMITED
DIN 00782718 · ended Jun 3, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-CARBAMAZEPINE
200MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02407515 · ended Sep 4, 2024 · Disruption of the manufacture of the drug.
ResolvedTARO-CARBAMAZEPINE
200MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02407515 · ended Sep 4, 2024 · Disruption of the manufacture of the drug.
ResolvedTARO-CARBAMAZEPINE
100MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02367394 · ended May 1, 2026 · Disruption of the manufacture of the drug.
ResolvedTEGRETOL SUSPENSION
100MG · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02194333 · ended Jan 12, 2026 · Demand increase for the drug.
ResolvedTEVA-CARBAMAZEPINE
200MG · TABLET · TEVA CANADA LIMITED
DIN 00782718 · ended Sep 10, 2025 · Disruption of the manufacture of the drug.
ResolvedTARO-CARBAMAZEPINE
100MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02367394 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ-CARBAMAZEPINE CR
200MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02261839 · ended Jul 29, 2024 · Disruption of the manufacture of the drug.
ResolvedSANDOZ-CARBAMAZEPINE CR
400MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02261847 · ended Jul 2, 2024 · Disruption of the manufacture of the drug.
ResolvedTEGRETOL CR
200MG · TABLET (EXTENDED-RELEASE) · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 00773611 · ended Jul 18, 2024 · Demand increase for the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Carbamazepine is currently affected by 2 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC, BIOMED PHARMA.
The reported causes are: disruption of the manufacture of the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Carbamazepine is classified under “ANTIEPILEPTICS” (ATC N03AF).
Recent changes
Common questions
When will Carbamazepine be back in stock in Canada?
The latest manufacturer estimate is Jun 26, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Carbamazepine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All antiepileptics shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.